Learnings on early antiplatelet therapy from registries
ESC, September 3, 2013
The symposium Early Initiation of antiplatelet therapy:Pre-treatment in ACS, facts and fictions was held at the congress of the European Society of Cardiology (ESC) in Amsterdam on September 3, 2013. A videopresentation from the lecture by Peter Clemmensen MD (The Heart Center, Rigshospitalet Copenhagen, Denmark) Learnings on early initiation of antiplatelet therapy from registries is now available on this website.
The goal of this program is to improve the knowledge with regard to peri- and post procedural management of ACS. After attending this program, the clinician will be better able to:
- Evaluate the cardiovascular risk associated with ACS
- Describe current treatment options for ACS and assess the proportion of patients eligible for percutaneous coronary intervention (PCI)
- Describe the need for peri- and post procedural platelet inhibition
- Understand the role of platelet inhibition in clinical outcomes of patients with ACS undergoing PCI
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.